Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$651.80 USD
-2.24 (-0.34%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $650.60 -1.20 (-0.18%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
For Regeneron Pharmaceuticals, Inc., the company has a dividend yield of 0.54% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
REGN 651.80 -2.24(-0.34%)
Will REGN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for REGN based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for REGN
REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase
Compared to Estimates, Regeneron (REGN) Q3 Earnings: A Look at Key Metrics
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates
Sanofi Q3 Earnings Beat, Dupixent Drives Growth as Vaccines Decline
REGN Q3 Earnings: Will Higher Dupixent Profits Offset Eylea Sales Decline?
Other News for REGN
Insider Moves: Blackstone, Regeneron, Schwab, Celestica, Corning
REGN forms Upper Bollinger Band Walk on October 31
Director’s Bold Move: Regeneron Stock Sale Shakes Up the Market!
Investor Michael Burry Warns Of Market Bubble
Upper Bollinger Band Walk appears for REGN after 0.17% move